Business Description

Omega Healthcare Investors Inc
NAICS : 531120
SIC : 6798
Description
Omega Healthcare Investors Inc is a healthcare facility real estate investment trust that invests in the United States real estate markets. Omega's portfolio focuses on long-term healthcare facilities. The company maintains dual goals of increasing its returns to investors while also maintaining a high level of care for residents. Omega works to obtain contractual rent escalations under long-term leases, along with fixed-rate mortgage loans. The company considers merger and acquisition investment as a component of its operational growth strategy.
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.03 | |||||
Equity-to-Asset | 0.39 | |||||
Debt-to-Equity | 1.43 | |||||
Debt-to-EBITDA | 5.35 | |||||
Interest Coverage | 1.68 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 0.82 | |||||
Beneish M-Score | -2.87 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 1.1 | |||||
3-Year EBITDA Growth Rate | 3 | |||||
3-Year EPS without NRI Growth Rate | 7.7 | |||||
3-Year FCF Growth Rate | 14.4 | |||||
3-Year Book Growth Rate | -1.4 | |||||
Future 3-5Y Total Revenue Growth Rate | -8.01 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 42.16 | |||||
9-Day RSI | 48.5 | |||||
14-Day RSI | 49.44 | |||||
6-1 Month Momentum % | -12.76 | |||||
12-1 Month Momentum % | -1.55 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.1 | |||||
Quick Ratio | 4.1 | |||||
Cash Ratio | 0.43 | |||||
Days Sales Outstanding | 71.84 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 9.31 | |||||
Dividend Payout Ratio | 1.55 | |||||
3-Year Dividend Growth Rate | 0.5 | |||||
Forward Dividend Yield % | 9.31 | |||||
5-Year Yield-on-Cost % | 10.43 | |||||
3-Year Average Share Buyback Ratio | -5.7 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 98.5 | |||||
Operating Margin % | 51.79 | |||||
Net Margin % | 42.17 | |||||
ROE % | 10.74 | |||||
ROA % | 4.28 | |||||
ROIC % | 5.46 | |||||
ROC (Joel Greenblatt) % | 555.1 | |||||
ROCE % | 7.02 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Price-to-FFO | 11.94 | |||||
PE Ratio | 16.04 | |||||
Forward PE Ratio | 10.78 | |||||
PE Ratio without NRI | 16.04 | |||||
Shiller PE Ratio | 17.1 | |||||
Price-to-Owner-Earnings | 12.7 | |||||
PEG Ratio | 80.2 | |||||
PS Ratio | 7.15 | |||||
PB Ratio | 1.82 | |||||
Price-to-Tangible-Book | 2.21 | |||||
Price-to-Free-Cash-Flow | 11.4 | |||||
Price-to-Operating-Cash-Flow | 11.21 | |||||
EV-to-EBIT | 18.19 | |||||
EV-to-Forward-EBIT | 21.66 | |||||
EV-to-EBITDA | 12.15 | |||||
EV-to-Forward-EBITDA | 13.64 | |||||
EV-to-Revenue | 13.86 | |||||
EV-to-Forward-Revenue | 15.14 | |||||
EV-to-FCF | 19.72 | |||||
Price-to-Projected-FCF | 0.88 | |||||
Price-to-Median-PS-Value | 0.86 | |||||
Price-to-Peter-Lynch-Fair-Value | 3.26 | |||||
Price-to-Graham-Number | 1.27 | |||||
Earnings Yield (Greenblatt) % | 5.5 | |||||
Forward Rate of Return (Yacktman) % | 12.71 |